lartesertib

N/A

Report date: 2025/06/16 14:41:08
NME

Base Information

Drug Namelartesertib
Drug Alias NameM-4076
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine-protein kinase ATM inhibitors
TargetsSerine-protein kinase ATM
Therapy Area/IndicationsSolid tumoursOvarian NeoplasmsCarcinoma, Ovarian Epithelial +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[15
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesMerck KGaA, Darmstadt, Germany
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursOvarian NeoplasmsCarcinoma, Ovarian Epithelial
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A